The molecular mechanisms linking the stress of unfolded proteins in the endoplasmic reticulum (ER stress) to glucose intolerance in obese animals are poorly understood. In this study, enforced expression of a translation initiation factor 2a (eIF2a)-specific phosphatase, GADD34, was used to selectively compromise signaling in the eIF2(aP)-dependent arm of the ER unfolded protein response in liver of transgenic mice. The transgene resulted in lower liver glycogen levels and susceptibility to fasting hypoglycemia in lean mice and glucose tolerance and diminished hepatosteatosis in animals fed a high-fat diet. Attenuated eIF2(aP) correlated with lower expression of the adipogenic nuclear receptor PPARg and its upstream regulators, the transcription factors C/EBPa and C/EBPb, in transgenic mouse liver, whereas eIF2a phosphorylation promoted C/EBP translation in cultured cells and primary hepatocytes. These observations suggest that eIF2(aP)-mediated translation of key hepatic transcriptional regulators of intermediary metabolism contributes to the detrimental consequences of nutrient excess.
INTRODUCTION
Eukaryotic cells respond to fluctuations in the load of unfolded proteins in the endoplasmic reticulum (ER) by an unfolded protein response (UPR). The oldest arm of the UPR, which is conserved in all eukaryotes, is mediated by IRE1, an ER stress-regulated kinase/endoribonuclease that signals through a transcription factor, XBP-1 (Hac1p in yeast), to activate UPR target genes. In animals, XBP-1 is joined by ATF6, a transcription factor that senses ER stress directly, to activate genes that enhance cells' ability to cope with the load of unfolded proteins facing their ER (reviewed in Schroder and Kaufman, 2005; Bernales et al., 2006) . These transcriptional events are complemented by a third arm of the UPR mediated by PERK, an ER-localized stress-activated kinase whose only known substrate is the a subunit of translation initiation factor 2 (eIF2a). Phosphorylation of eIF2a on serine 51 inhibits the guanine nucleotide exchange factor for eIF2 and reduces rates of translation initiation. The consequent repression of protein synthesis diminishes the load of unfolded proteins entering the ER and conserves ATP and amino acids in ER-stressed cells. eIF2(aP) also activates gene expression, which is accounted for, in part, by the translational upregulation of the transcription factor ATF4 (reviewed in Ron and Harding, 2007) .
Earlier studies emphasized the UPR's role in maintaining homeostasis of the protein-folding environment in the ER lumen, and its physiological significance was sought in the context of cellular adaptation to the stress posed by unfolded and misfolded ER proteins. The phenotype of mutations in components of the UPR is certainly consistent with this notion-knockout of IRE1, ATF6 , and PERK all reduce the ability of cells to cope with ER stress (Delepine et al., 2000; Harding et al., 2001; Shen et al., 2001; Zhang et al., 2002; Lee et al., 2005; Wu et al., 2007; Yamamoto et al., 2007) . However, accrued evidence now suggests that ER stress and the response to it modulate mammalian physiology in ways that cannot be explained simply by the aforementioned cell-autonomous processes.
In addition to imparting hypersensitivity to ER stress, a homozygous Eif2a S51A mutation (which abolishes regulatory phosphorylation of eIF2a) blocks hepatic glucose production in neonatal mice (Scheuner et al., 2001) . By contrast, heterozygosity for the same Eif2a S51A mutation disposes adult mice to obesity, insulin resistance, and glucose intolerance (Scheuner et al., 2005) . Obesity promotes ER stress, presumably by increasing the load of unfolded proteins in the ER, which is detected as enhanced UPR signaling in liver and fat (Ozcan et al., 2004; Nakatani et al., 2005) . Importantly, compromised signaling in the UPR by a partial loss-of-function mutation in XBP-1 (which further increases the level of ER stress) or a mutation in the ER chaperone ORP150 increases insulin resistance in obese mice (Ozcan et al., 2004; Nakatani et al., 2005) , whereas chemical chaperones or ORP150 overexpression that reduces the level of ER stress substantially reverse the insulin resistance and glucose intolerance of obese mice Ozcan et al., 2006) . These studies imply that ER stress, or aspects of the response to it, modulate intermediary metabolism in a manner that cannot be simply attributed to variation in survival of secretory cells. Several kinases phosphorylate eIF2a to activate a downstream gene expression program that we refer to as the integrated stress response (ISR) . In yeast, a GCN2-mediated eIF2(aP)-dependent transcriptional program responds to diverse metabolic perturbations (Hinnebusch and Natarajan, 2002) , and the homologous mammalian eIF2a kinase is also implicated in metabolic regulation (Hao et al., 2005; Maurin et al., 2005; Guo and Cavener, 2007) . These observations suggest that links between metabolic regulation and eIF2a phosphorylation are conserved and might contribute to the physiological response to ER stress in mammals. Here we have focused on eIF2(aP) signaling in the liver, a key organ for intermediary metabolism, and present evidence that the hepatic ISR contributes to the metabolic syndrome of obesity and insulin resistance by translational upregulation of transcription factors involved in carbohydrate and lipid metabolism.
RESULTS
The major determinant of ISR activity in liver is the ER stressactivated kinase PERK, whose transient activation is difficult to detect . To determine whether the ISR is modulated by normal fluctuations in nutrient intake, we first monitored two perdurable markers, BiP and XBP-1 mRNA, as surrogates for the UPR (and PERK activity). Feeding coincided with a clear peak of these marker mRNAs (see Figure S1A available online), suggesting that physiological ER stress is induced by feeding, as predicted by previous studies (Dhahbi et al., 1997) . To gauge the transient phosphorylation of eIF2a, we fasted animals for 18 hr and refed them with normal (low-fat) and high-fat chow. Levels of eIF2(aP) were barely detectable in liver after a 18 hr fast but increased 4 hr after feeding with ordinary chow and were even higher in animals provided high-fat chow ( Figure S1B ). These observations confirmed the previously noted (Ozcan et al., 2004) correlation between physiological nutritional fluctuations and the eIF2(aP)-dependent ISR in liver.
Selective Attenuation of the ISR in Liver of Transgenic Mice
To study the potential significance of physiological levels of eIF2(aP) in mouse liver, we sought to selectively interfere with this phosphorylation event. Gadd34 (PPP1R15a) encodes a substrate-specific regulatory subunit of a phosphatase that selectively dephosphorylates eIF2a phosphoserine 51 (Novoa et al., 2001) . Gadd34 activity is tightly regulated at the transcriptional level, and the gene is normally turned on by the ISR as part of a negative feedback loop that terminates signaling ; however, enforced expression of an active C-terminal fragment of GADD34 is sufficient to dephosphorylate eIF2(aP) and inhibit the ISR (Novoa et al., 2001) . We exploited this feature by expressing a GADD34 C-terminal fragment from a liver-specific albumin (Alb) promoter in transgenic mice. The GADD34 C-terminal active fragment (GC) was detected by immunoblot in liver lysates of transgenic Alb::GC mice ( Figure 1A ). Expression of a single copy of the transgene attenuated feedinginduced eIF2a phosphorylation, and two copies of the transgene blocked phosphorylation even during severe ER stress in mice injected with tunicamycin ( Figure 1A ). We conclude that the Alb::GC transgene interferes with eIF2a phosphorylation in the liver.
To estimate the consequences of the Alb::GC transgene on the eIF2(aP)-mediated ISR and to generate a hypothesis for possible mechanisms, we established a reference database for the activity of this pathway in the liver. PERK's kinase activity can be uncoupled from ER stress by fusion of the cytosolic PERK kinase domain to an artificial dimerization domain (Fv2E) that subordinates eIF2a phosphorylation to a soluble, otherwise inert ligand, AP20187 (Lu et al., 2004b) (Figure S2A ). In the absence of ligand, the Fv2E-PERK chimera, expressed in the liver of transgenic mice (Ttr::Fv2E-Perk), is inert. However, following intraperitoneal (i.p.) injection of AP20187, the chimeric protein is activated (reflected by a shift in its mobility on SDS-PAGE) and phosphorylates its substrate ( Figure 1B ). The Chop marker gene was used to confirm the ligand and gene dose-dependent activation of the ISR in the liver of Ttr::Fv2E-Perk mice ( Figures  1C and 1D ; Figure S2B ), and a profile of genes thereby induced was assembled using oligonucleotide hybridization microarrays of liver mRNA. About half of the genes previously identified as ISR targets in fibroblasts Lu et al., 2004b) were also induced in the liver of the transgenic mice following injection of AP20187 ligand ( Figure 1E ; Table S1 ).
Next, we sought to determine whether the Alb::GC transgene, which blocked eIF2a phosphorylation, interfered with expression of this hypothesized set of ISR genes in liver. As feeding of a high-fat diet (HFD) promotes eIF2(aP) in the liver, we compared the profile of genes expressed in the liver of wild-type and Alb::GC mice fed high-fat or low-fat chow. As expected, the genes constituting the hepatic ISR were expressed at higher levels in the liver of HFD-fed wild-type mice. These diet-induced differences in expression were attenuated by the Alb::GC transgene (Figure 1E , bottom; same data in Table S2 ), suggesting that the latter blocks signaling in a diet-induced ISR and that such mice might constitute a useful tool for studying the role of this pathway in metabolism.
Metabolic Profile of the ISR-Defective Alb::GC Mice Apart from slight gene-dosage-dependent reduced body mass (Figure 2A ), adult Alb::GC mice were superficially indistinguishable from wild-type littermates when fed a normal diet. However, they were markedly impaired in defending blood glucose during a fast ( Figure 2B ). This functional defect correlated with diminished hepatic glycogen reserves ( Figures 2C and 2D ) and attenuated glucose production in response to pyruvate loading (a measure of gluconeogenesis) in fasted Alb::GC mice compared with wild-type ( Figure 2E) .
A tendency toward fasting hypoglycemia may also explain the high rates of perinatal attrition of Alb::GC transgenic mice (21 of 58 pups were found dead at postnatal day 1 in Alb::GC transgenic litters compared with 1 of 41 pups in the wild-type FVB/n control; p < 0.05 by c 2 test), a defect they share with homozygous Eif2a S51A mice (Scheuner et al., 2001) . Consistent with these observations, Alb::GC mice also had enhanced glucose tolerance in experimental surrogates of the fed state, as reflected in lower serum glucose levels following i.p. injection of glucose (i.p. GTT, Figure 2F ) and enhanced sensitivity to the hypoglycemic effects of injected insulin (i.p. ITT, Figure 2G ).
To analyze the ISR's role in the context of nutrient excess, we combined dietary manipulation with aurothioglucose injection, thus overcoming the known resistance of FVB/n mice (the background for the wild-type and transgenic mice studied here) to diet-induced obesity (Hu et al., 2004) . Between 6 and 21 weeks of age, the body weight of wild-type mice increased 2.43 ± 0.16-fold, and that of the Alb::GC transgenic mice increased by 1.96 ± 0.08-fold (mean ± SEM, n = 12, p < 0.05) ( Figure 3A ). The resulting glucose intolerance and insulin resistance were also less in the Alb::GC mice compared to the wildtype mice ( Figures 3B-3D ). Hepatic steatosis, a predictable feature of obese wild-type male animals, was also significantly lower in ISR-defective mice fed a HFD, as reflected in a lower histochemical steatosis index of 0.8 ± 0.2 (mean ± SEM) in Alb::GC versus 6.4 ± 0.2 in wild-type (n = 5, p < 0.005; see also Figure 3E ) (Kleiner et al., 2005) and lower liver tissue triglyceride content: 10.72 ± 1.69 mg/gm in Alb::GC versus 21.34 ± 4.11 mg/gm in wild-type (mean ± SEM, n = 5, p < 0.05) ( Figure 3F ).
The ISR Regulates Genes Involved in Intermediary Metabolism
Two transcription factors are known to be activated by eIF2(aP): ATF4, whose translation is paradoxically stimulated (Harding et al., 2000; Lu et al., 2004a; Vattem and Wek, 2004) , and NF-kB, which undergoes derepression in the ISR (Jiang et al., 2003; Deng et al., 2004) . However, defective signaling to their targets seemed unlikely to explain the altered hepatic gene expression program or the metabolic phenotype of the Alb::GC mice (Table S3 ). Therefore, in our search for potential mediators of the metabolic effects of the ISR, we focused on other transcription factor-encoding genes that were differentially expressed in wild-type and Alb::GC mice. At the top of this list was peroxisome proliferator-activated receptor g (PPARg; Pparg) ( Table 1) .
Originally identified as an activator of adipocyte differentiation (reviewed in Rosen et al., 2000; Farmer, 2006) Table S1 ). The inset at the bottom left depicts the expression level of a subset of these validated hepatic ISR target genes (those that are induced more than 2-fold by AP20187 expression in both Ttr::Fv2E-PERK transgenic lines) in high-fat diet (HFD)-fed nontransgenic (WT, n = 2) and Alb::GC transgenic (GC/GC, n = 2) animals (data in Table S2 ).
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The ISR and Intermediary Metabolism revealed that PPARg mRNA levels were $2.7-fold lower in the liver of HFD-fed Alb::GC mice compared to wild-type ( Figure 4A ). Profiling also suggested a corresponding lower expression of PPARg target genes involved in fatty acid synthesis in the Alb::GC transgenic mice (Table 1) , which was confirmed by quantitative RT-PCR analysis of fatty acid synthetase (Fasn), acetyl-CoA carboxylase a and b (Acaca and Acacb), and stearoyl-CoA desaturase(Scd1) ( Figures 4B-4E ). This analysis places Pparg downstream of the ISR in the liver and suggests that its lower expression might contribute to reduced hepatic steatosis in Alb::GC transgenic mice.
Translational Activation of C/EBP Proteins by the ISR
In adipocytes, CCAAT/enhancer-binding protein b (C/EBPb) and the related C/EBPa isoform positively regulate PPARg expression through self-reinforcing feed-forward loops (reviewed in Rosen et al., 2000; Farmer, 2006) . Recent data suggest that this relationship extends to the liver, as Cebpb deletion reduces levels of PPARg2 mRNA and lipid accumulation in the liver of obese mice (Millward et al., 2007; Schroeder-Gloeckler et al., 2007) . Furthermore, C/EBP proteins also promote glycogen synthesis and hepatic glucose production Liu et al., 1999) . These features are shared by the ISR-defective Eif2a S51A mice (Scheuner et al., 2001 ) and the Alb::GC mice here (Figure 2 and Figure 3 ), prompting us to further probe the relationship of the ISR to C/EBP expression.
Levels of C/EBPb protein were more than 2-fold lower in nuclei isolated from livers of Alb::GC mice than in nuclei isolated from wild-type livers, and similar differences were observed in the abundance of C/EBPa ( Figures 5A and 5B) . Given that the ISR regulates its best known target, ATF4, translationally (Harding et al., 2000; Lu et al., 2004a; Vattem and Wek, 2004) and that isoform choice among C/EBP proteins has previously been shown to be regulated translationally by the virally induced eIF2a kinase PKR (Calkhoven et al., 2000) , we decided to determine whether the effects of the ISR on C/EBP protein levels also have a translation component.
The incorporation of [ 35 S]methionine/cysteine into newly synthesized C/EBPa and C/EBPb was measured by pulse labeling followed by immunoprecipitation. Activation of the ISR by AP20187 in Fv2E-PERK-expressing chinese hamster ovary cells led to an $2-fold increase in label incorporated into newly synthesized endogenous proteins ( Figure 5C ). This increase occurred in the face of global repression of protein synthesis, reflected here in the incorporation of label into the transcription factor CREB ( Figure 5C ) and eIF2a ( Figure 5D ). As activated Fv2E-PERK phosphorylates eIF2a without causing ER stress, these findings suggest that the ISR can enhance C/EBP translation independently of other signaling pathways.
To extend these observations to a surrogate of the liver ISR, a similar analysis was performed in HepG2 hepatoma cells in which PERK was activated by thapsigargin. Incorporation of label into newly synthesized C/EBPa and C/EBPb increased $2-fold within 30 min of treatment. Furthermore, the increase in translation observed over 30 min of ISR induction in the thapsigargin-treated HepG2 cells was sustained in the face of transcriptional inhibition by actinomycin D (Figure 5D ), attesting to its independence of new mRNA synthesis. The effectiveness of actinomycin D in inhibiting mRNA synthesis is revealed by the block to activation of a transcriptional target of the ISR, CHOP ( Figure 5D , inset). To determine whether attenuating the ISR by Alb::GC expression affects translational induction of C/EBP in hepatocytes, we compared the incorporation of labeled methionine/cysteine into C/ EBPb in untreated and thapsigargintreated primary hepatocytes explanted from wild-type and Alb::GC transgenic mice. Thapsigargin reproducibly enhanced the incorporation of label into immunopurified C/EBPb in wild-type, but not Alb::GC transgenic, hepatocytes ( Figures  5E and 5F ). As expected, attenuation of total protein synthesis by thapsigargin was also less conspicuous in the Alb::GC transgenic sample. The rapid dedifferentiation of cultured primary hepatocytes likely leads to an underestimate of the transgene's effect in vivo. Dedifferentiation may also account for our inability to detect labeled C/EBPa in these samples.
The physiological significance of regulated expression of C/ EBP isoforms by the ISR is supported by the finding that genes encoding key enzymes in hepatic glucose metabolism that are known to be regulated by C/EBPs were reduced in the Alb::GC transgenic mice. This relationship extended across a range of physiological states from normal feeding ( Figure 5G ) to animals in which diabetes mellitus had been induced by streptozotocin injection ( Figure 5H) .
Expression profiling revealed that many ISR target genes were induced to lower levels in the livers of transgenic mice from the line expressing more Fv2E-PERK ( Figure 1E ; Table S1 ). This finding suggested negative feedback in the ISR, for example by CHOP, a late downstream transcription factor induced by the ISR (Harding et al., 2000) that inhibits conventional C/EBP target
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The ISR and Intermediary Metabolism genes (Ron and Habener, 1992) and blocks adipocytic differentiation (Batchvarova et al., 1995) , or another transcriptional target of the ISR, ATF3, which inhibits ATF4 (Jiang et al., 2004) . To explore this suggestion of biphasic regulation of gene expression by the ISR, we injected Ttr::Fv2E-PERK transgenic animals (of the lower-expressing line) with increasing amounts of the AP20187 activator and measured mRNA levels in their livers by RT-PCR. While CHOP, ATF3, and C/EBPb mRNA levels increased monophasically with AP20187 dose, other genes such as Pparg, Pck1 (Pepck), and other C/EBP target genes responded biphasically ( Figure 6A ). These observations suggest that at lower levels of signaling, the ISR contributes positively to the regulation of the same metabolic pathways that it inhibits at unusually high, possibly pathological, levels of signaling.
DISCUSSION
By focusing on one branch of the UPR-the eIF2(aP)-mediated ISR-and by restricting the genetic manipulation to a single tissue-the liver-this study clarifies earlier work in mice with pervasive alterations in the ER stress response that were effected by germline mutations in UPR pathway genes. Both the hepatic ISR-defective Alb::GC mice described here and globally ISR-defective homozygous Eif2a S51A mutant mice (Scheuner et al., 2001 ) share a tendency toward fasting hypoglycemia and reduced hepatic glycogen content. This argues that at least some of the metabolic consequences of a defective ISR are autonomous to the hepatocyte. The aforementioned hepatic defect is well explained by lower levels of C/EBPa and b protein in the liver of Alb::GC mice, as both C/EBPa and b are known to positively regulate genes involved in glycogen synthesis and hepatic glucose production Liu et al., 1999) . Our findings argue that ISR-mediated activation of C/EBPa and b can proceed by a translational mechanism that is mobilized within minutes of induction of eIF2a phosphorylation and functions independently of new mRNA synthesis. Translational activation is aided by previously recognized transcriptional upregulation, which likely reinforces further C/EBP expression . In these respects, the C/EBPs resemble the well-validated translational target of the mammalian ISR, ATF4, and its yeast counterpart, GCN4. However, the arrangement of conserved upstream open reading frames in the C/EBPa and b genes suggests important differences between the molecular mechanism by which eIF2(aP) promotes their translation and that of ATF4/GCN4. Two conserved upstream open reading frames specify regulated translational reinitiation at the ATF4 (and GCN4) coding sequence when levels of phosphorylated eIF2a are high (Hinnebusch and Natarajan, 2002; Lu et al., 2004a; Vattem and Wek, 2004) . In the case of C/EBPa and b, our observations and those of Calkhoven and colleagues (2000) are more readily explained by a model whereby eIF2(aP) disfavors initiation at the single inhibitory short open reading frame conserved in their mRNAs and favors initiation at one or more downstream AUGs. The mechanism linking eIF2(aP) to regulated initiation at two consecutive open reading frames remains to be resolved; however, the phenomenon is not restricted to C/EBPa and b, as it is observed on the ATF4 mRNA when the 5 0 -most of the two upstream open reading frames is deleted (see Figure 5B in Lu et al., 2004a).
Our study also implicates the ISR in regulating lipid metabolism in the liver, as Alb::GC mice accumulated less neutral lipid in their livers when placed on a HFD. This alteration, too, appears to be mediated by changes in gene expression, as levels of enzymes involved in fatty acid synthesis were lower in the ISRdefective transgenic mice compared with the wild-type. Lower levels of PPARg might explain part of this defect, as a requirement for hepatic PPARg in the development of hepatic steatosis has been noted recently (Gavrilova et al., 2003) . C/EBP proteins positively regulate PPARg expression (Millward et al., 2007; Rahman et al., 2007) , which is consistent with a linear pathway from eIF2(aP) to the C/EBP proteins and from there to PPARg (Figure 6B) . Furthermore, the ISR-defective Alb::GC transgenic mice gain significantly less weight when placed on a HFD. While a detailed understanding of the physiological mechanisms awaits further studies, the pervasive role of eIF2(aP) in regulating genes involved in glycogenesis and lipid synthesis is consistent with the idea that impaired conversion of ingested nutrients to their storage forms limits weight gain in these ISR-defective animals.
In cultured cells, transient activation of the ISR promotes survival and adaptation whereas unremitting signaling promotes cell death (Rutkowski et al., 2006) . The observations made here provide an interesting parallel in terms of intermediary metabolism in the liver: low-level signaling in the ISR (as observed under physiological circumstances) promotes expression of genes involved in glycogen synthesis, gluconeogenesis, and fatty acid synthesis, whereas higher levels of signaling repress the expression of the same genes. These findings might be explained by differential responsiveness of the ISR's effectors to signaling at different intensities, as proposed by Rutkowski et al. (2006) . CHOP, ATF3, and C/EBPb mRNA levels increase monophasically with signal strength, but expression of downstream C/ EBP target genes declines at high levels of ISR activity (Figure 6A) . CHOP-mediated inhibition of C/EBP proteins (Ron and Habener, 1992) Biphasic regulation of enzymes involved in fatty acid biosynthesis may also explain an apparent discrepancy between this study, in which signaling in the hepatic ISR is shown to promote steatosis in mice fed a HFD, and the observation that global Gcn2 deletion predisposes mice fed a leucine-deficient diet to steatosis (Guo and Cavener, 2007) . Perhaps leucine deficiency is associated with levels of ISR signaling that repress lipid synthesis in wild-type mice but fail to achieve this level in Gcn2 À/À mice. Alternatively, the lower levels of amino acid transporters noted in ISR-defective cells may further reduce hepatic uptake of leucine and sensitize amino aciddeprived Gcn2 À/À mice to fatty liver by further reducing the building blocks for lipoprotein synthesis and thereby lipid export. It has previously been reported that a partial compromise in downstream signaling in the IRE1 branch of the UPR (effected by haploid insufficiency for Xbp1) accentuates insulin resistance and promotes glucose intolerance in obese mice (Ozcan et al., 2004) and that protein and chemical chaperones that reduce ER stress in insulin target tissues ameliorate that phenotype Ozcan et al., 2006) . Our study suggests 
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The ISR and Intermediary Metabolism Shown are genes induced R2-fold by high-fat diet (HFD) feeding in wild-type (WT) mice and reduced by at least 25% in HFD-fed Alb::GC transgenic mice compared to HFD-fed WT. ''HFD induction'' is the ratio of the hybridization signals in HFD-fed versus low-fat diet (LFD)-fed mice. ''% of WT in GC HFD'' is the percentage of the signal of HFD-fed WT observed in HFD-fed Alb::GC (GC) mice. The mean ± standard deviation of the expression level (see Experimental Procedures) in WT and Alb::GC from two independent mice is shown. The uppermost cluster is a list of genes encoding transcription factors that satisfy the above criteria but are also induced R2-fold in AP20187-injected (0.2 mg/gm body weight) high-expressing Ttr::Fv2E-PERK (line #30) transgenic mice. The three clusters below list genes involved in carbohydrate, lipid, and amino acid metabolism that satisfy the above criteria.
a parallel process operating in hepatocytes, whereby heightened activity of the ISR and its downstream target genes contributes to the link between (physiological) ER stress and the metabolic syndrome of obesity and diabetes. In regard to intermediary metabolism, signaling by IRE1 and the ISR proceed in parallel, and neither seems to dominate the metabolic phenotype. This is exemplified by observations that insulin signaling to its proximal targets is not obviously affected by the ISR perturbation (data not shown), whereas such a defect is predicted in a system dominated by IRE1 signaling. Though loss of translational control in the ISR-defective state leads to more IRE1 signaling, which impairs insulin signaling, our study suggests that the net effect of a compromised ISR is to ameliorate the metabolic phenotype in mice exposed to nutrient excess. It is interesting to speculate on the evolutionary origins of the link between the ISR and intermediary metabolism. Gene knockout experiments show that in most mammalian tissues, the ER stress-inducible kinase PERK dominates ISR activity . However, the GCN2-posessing ancestor in which PERK first evolved already had in place a gene expression program responsive to eIF2(aP) that modulated intermediary metabolism (Hinnebusch and Natarajan, 2002) . We propose that this preexisting link was co-opted by PERK to coordinate intermediary metabolism with nutritionally entrained variation in load of unfolded client proteins that enter the ER of insulin-responsive tissues. This model is supported by the observation that yeasts, which lack PERK, also use ER activity as a proxy for nutrient availability but effect this by IRE1 signaling (Schroder et al., 2000; Patil et al., 2004) . Presumably, under conditions of limited nutrient availability, this fine tuning of intermediary metabolism by physiological levels of ER stress signaling is adaptive; however, in the presence of excess nutrients, the ISR's contributions to lipid synthesis and hepatic glucose production are counterproductive and promote glucose intolerance and liver steatosis. Time will tell whether this example of failure of homeostasis can be exploited therapeutically, by targeting distinct facets of the ISR with inhibitors.
EXPERIMENTAL PROCEDURES
Transgenic Mice A 2.3 kb mouse albumin enhancer/promoter fragment was used to drive expression of hamster GADD34 (aa 292-590) in the Alb::GC transgene. Two transgenic lines, #14 and #16, were established in the FvB/n strain. These lines exhibited similar sensitivity to fasting hypoglycemia, and the higher-expressing line, #14, was used in subsequent studies.
As we were unable to obtain lines expressing Fv2E-PERK using the Alb promoter, the transthyretin (Ttr) promoter was used instead to produce six Ttr::Fv2E-Perk transgenic lines in FvB/n, two of which, expressing the protein at different levels (#30 ''high'' and #58 ''low''; Figure S2B ), were selected for further study. For the experiment reported in Table S3 , the low-expressing Ttr::Fv2E-Perk transgenic line (#58) was bred into the Atf4 knockout strain, the derivative compound heterozygous mice (in the mixed FvB/n; Swiss Webster background) were backcrossed to the Atf4 +/À parental stock, and Ttr::Fv2E-PERK-positive siblings with Atf4 +/+ and Atf4 À/À genotypes were analyzed.
Animal Experiments
All experiments in mice were approved by the New York University School of Medicine Institutional Animal Care and Use Committee. Because of their enhanced susceptibility to the metabolic consequences of nutrient excess, male mice were used. These animals were maintained on low-fat diet (LFD) containing 12% fat or high-fat diet (HFD) containing 60% fat (Research Diets #D12492) with 12 hr light and dark cycles. To induce hypoinsulinemic diabetes, streptozotocin (100 mg/kg, Sigma) freshly dissolved in citrate buffer (pH 4.5) was injected i.p. into 10-to 12-week-old mice on 2 consecutive days.
For diet-induced obesity, aurothioglucose (0.5 mg/g, Schering-Plough) was injected i.p. as a single dose into 6-week-old mice.
For the glucose tolerance test, mice were fasted overnight (14 hr) and injected i.p. with a glucose solution (2 g/kg). For the insulin tolerance test, mice were fasted for 4 hr and injected i.p. with human insulin (0.75 mU/kg, Eli Lilly). For pyruvate loading, mice were fasted for 16 hr and injected i.p. with 1.5 g/kg sodium pyruvate. Blood glucose and plasma insulin concentrations were measured from tail blood using a OneTouch Ultra glucometer (Johnson & Johnson) and a rat/mouse insulin ELISA kit (Linco Research), respectively.
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The ISR and Intermediary Metabolism To determine liver glycogen content, livers (100-150 mg) were digested in 0.3 ml of 30% KOH for 30 min at 100 C, followed by addition of 0.1 ml of 20% NaSO 4 and 0.8 ml of ethanol. Macromolecules containing glycogen were precipitated by centrifugation (20,000 3 g, 10 min) and washed with 70% ethanol. The pellets were hydrolyzed in 0.5 ml of 4 N H 2 SO 4 for 10 min at 100 C and neutralized by 0.5 ml of 4 N NaOH. To measure glucose concentration, 5 ml of the sample supernatant was added in a glucose (HK) assay reagent (Sigma). Liver glycogen concentration was determined by comparison with a standard curve constructed by glycogen from oyster type II (Sigma). Triglyceride content of liver tissue was measured enzymatically (L-Type TG H test, Wako Pure Chemical Industries) on lipids extracted from tissue samples with chloroform:methanol (2:1 mix).
Histological Analysis
Livers from animals perfused with 10% paraformaldehyde were fixed in the same, paraffin embedded, sectioned in 5 mm slices, and stained with hematoxylin and eosin or periodic acid-Schiff (PAS). Oil red O was used to stain neutral lipids in frozen liver sections. Hepatic steatosis was assessed in three categories-grade, location, and microvesicularity-and a composite score was obtained (based on Kleiner et al., 2005) .
RNA Analysis
Livers were snap frozen in liquid nitrogen, and total RNA was isolated using RNA-STAT60 (Tel-Test) and an RNeasy Mini Kit (QIAGEN). For gene expression profiling, total RNA was fluorescently labeled and hybridized to Affymetrix mouse genome 430A 2.0 GeneChip or Affymetrix murine genome U74Av2 GeneChip under standard conditions. Primary image analysis of the arrays was performed using GeneChip 3.2 software (Affymetrix). The raw data from the hybridization experiments were analyzed by GeneSpring GX (Agilent Technologies). The raw signal from each gene was normalized to the mean strength of all genes from the same chip to obtain the normalized signal strength. Then, to allow visualization of all data on the same scale for subsequent analysis, the normalized signal strength of each gene was divided by the median signal strength for that gene among all samples to obtain the normalized expression level.
Quantitative RT-PCR was performed with the iScript One-Step RT-PCR kit using the MyiQ single-color real-time PCR detection system (Bio-Rad Laboratories). All PCR reactions were performed in duplicate or triplicate, and PCR products were subjected to a melting curve analysis. The abundance of specific mRNAs was determined by comparison with a standard curve constructed by serial dilution of the sample and normalized to b-actin. Primers used for PCR reactions are listed in Table S4 .
Cell Culture HepG2 cells were cultured in regular DMEM supplemented with 10% FetalClone II serum (Hyclone) and penicillin-streptomycin. CHO-KI cells were grown in Ham's F12 supplemented with 10% FetalClone II serum and penicillin-streptomycin.
Primary hepatocytes were isolated from wild-type and Alb::GC mice, cultured on type I collagen-coated plates in Waymouth's medium supplemented with 0.1 nM insulin, and metabolically labeled as described previously (Oyadomari et al., 2006) .
Protein Analysis
PERK and GADD34 were detected in liver lysates by immunoprecipitation followed by immunoblotting as described or by direct immunoblotting of the lysates to detect phosphorylated and total eIF2a as described previously . C/EBPa, C/EBPb, and CREB were blotted in a nuclear extract prepared from liver. Antibodies for immunoprecipitation for GADD34 and PERK and immunoblotting procedures for eIF2a, GADD34, PERK, C/ EBPa, C/EBPb, and CREB have been described previously (Batchvarova et al., 1995; Harding et al., 2001; Novoa et al., 2001) . Phosphorylated eIF2a was detected using BioSource Ab #44-728G lot #0201.
The translation of C/EBPa, C/EBPb, ATF4, CREB, and eIF2a was measured by pulse labeling and immunoprecipitation in Fv2E-PERK-expressing CHO cells (Lu et al., 2004a) , HepG2 cells, and primary hepatocytes. For metabolic labeling, cells were switched to methionine and cysteine minus DMEM with 10% dialyzed fetal calf serum 5 min before addition of TRAN 35 S-LABEL (MP Biomedicals) at 400 mCi/ml for 30 min.
Statistical Analysis
All results are expressed as means ± SEM. Unpaired two-tailed Student's t tests were performed to determine p values for paired samples, and twoway ANOVA with repeat measurements was performed to analyze measurements obtained by time course.
ACCESSION NUMBERS
The complete data set for the data reported herein has been submitted to the NCBI GEO database (http://www.ncbi.nlm.nih.gov/geo/) with the accession numbers GSE11116 and GSE11210. Table S5 . (B) Summary of interactions between components of the ISR regulating intermediary metabolism.
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